Results 51 to 60 of about 268,545 (217)

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Changes of Body Mass Index and Lipid Profile in Injectable Depot Medroxyprogesterone Acetate and Levonorgestrel Implant Acceptors

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2014
Objective: To determine the comparison of body mass index (BMI) among acceptors of injectable depot medroxyprogesterone acetate (DMPA) with levonorgestrel implant acceptors for 1 year and comparison of lipid profiles between depot medroxyprogesterone ...
Irwan Daido   +2 more
doaj   +1 more source

Menstrual suppression to decrease intrauterine device expulsion in adolescents with inherited bleeding disorders

open access: yes
International Journal of Gynecology &Obstetrics, Volume 169, Issue 1, Page 421-423, April 2025.
Peter H. Cygan   +3 more
wiley   +1 more source

Family Planning Data and Measurement in the Era of Changing Global Development Architecture

open access: yesStudies in Family Planning, EarlyView.
Abstract Decades of progress in global sexual and reproductive health programming and data availability are threatened as over 80 percent of donor funding for family planning (FP) comes from governments that have announced significant cuts to official development assistance.
Shiza Farid   +13 more
wiley   +1 more source

Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate [PDF]

open access: yes, 2013
To evaluate contraceptive adherence to the copper intrauterine device (Cu-IUD) and the injectable depot medroxyprogesterone acetate (DMPA) among women with HIV in Lilongwe ...
Tweya, Hannock   +13 more
core   +1 more source

Menopause and vascular endothelial health: Is it all about the oestrogen?

open access: yesExperimental Physiology, EarlyView.
Abstract Cardiovascular disease (CVD) is a leading cause of mortality in women, and CVD risk is accelerated during the menopause transition. This acceleration has traditionally been attributed to the hallmark decline in oestradiol with menopause. However, the menopause transition is also characterized by changes in other sex hormones that exert effects
Virginia R. Nuckols   +4 more
wiley   +1 more source

Trends in monthly purchases for medroxyprogesterone acetate between Jan 2016 –Dec 2021 in Canada.

open access: yes, 2023
Medroxyprogesterone acetate did encounter a significant shift in drug purchasing trends as illustrated by ARIMA analysis. The range of drug purchases prior to the shortage was 1,383,928 SU to 2,080,376 SU, and 1,134,681 SU to 1,917,025 SU after the ...
Araniy Santhireswaran (17692141)   +7 more
core   +1 more source

Characterization of a novel telomerase-immortalized human endometrial stromal cell line, St-T1b

open access: yesReproductive Biology and Endocrinology, 2009
Background Coordinated differentiation of the endometrial compartments in the second half of the menstrual cycle is a prerequisite for the establishment of pregnancy. Endometrial stromal cells (ESC) decidualize under the influence of ovarian progesterone
Brosens Jan J   +6 more
doaj   +1 more source

Membranous dysmenorrhea and decidual casts: A scoping review

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 175, Issue 2, Page 544-553, November 2026.
Abstract Background Membranous dysmenorrhea, characterized by the expulsion of intact endometrial tissue rather than gradual dissolution during menstruation, occasionally presents as a decidual cast—a complete triangular mold of the uterine cavity. This poorly understood condition is likely underdiagnosed.
Lovisa Brehmer, Hedvig Engberg
wiley   +1 more source

Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro

open access: yes, 2011
Objective: The aim of the study was to investigate whether lithium chloride and medroxyprogesterone acetate can potentiate the cytotoxicity of imatinib mesylate in human endometrial cancer in vitro and the effect of midkine in these ...
Erguven, Mine   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy